Latest treatment of bipolar disorder Stories
WOODBRIDGE, ON, May 13, 2014 /PRNewswire/ - Pivotal Therapeutics Inc.
Therapist Researcher Al R Zia of Ann Arbor, MI produced amazing results in his first batch of clinical trials with Parkinson's Disease ended May 1st, 2014 via CranioSacral Integrative therapy.
BOSTON, May 12, 2014 /PRNewswire/ -- Verde Media Group Inc.
Dr. Robert Moss discusses the Clinical Biopsychology Model as a brain-based psychotherapy approach from its origin to its current status.
WOODBRIDGE, ON, May 7, 2014 /PRNewswire/ - Pivotal Therapeutics Inc.
Companion health economics analysis shows Transcranial Magnetic Stimulation (TMS) is cost-effective among patients who fail to benefit from prior antidepressant medication NEW YORK,
WOODBRIDGE, ON, May 6, 2014 /PRNewswire/ - Pivotal Therapeutics Inc.
Neuronetics, Inc. announced today results from a new, dual-arm randomized pilot study that showed a trend toward symptomatic improvements with once-monthly TMS maintenance therapy in medication-free patients treated with NeuroStar TMS Therapy® for Major Depressive Disorder (MDD).
Pilot Study Reveals a Majority of Medication-Free Patients Treated with NeuroStar TMS Experienced Remission After Six Weeks with Durable Effects Through Three Months NEW YORK, May
WOODBRIDGE, ON, May 1, 2014 /PRNewswire/ - Pivotal Therapeutics Inc.
- An imitative word; an onomatopoetic word.